FDA approves Santhera’s Agamree for Duchenne muscular dystrophy
HQ team October 31, 2023: The US Food and Drug Administration (FDA) has given the green light to Santhera Pharmaceuticals’ drug, Agamree (vamorolone),.
Drugs
Medical
Pharma